149 related articles for article (PubMed ID: 38371575)
1. Real-World Indian Experience of Switchover to Bilastine 40 mg/day in CSU Patient Refractory to Other Antihistamines at Double Dose.
De A; Shah B; Banodkar PD; Dhoot D; Chitnis K; Barkate H
Indian J Dermatol; 2023; 68(6):674-677. PubMed ID: 38371575
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
[TBL] [Abstract][Full Text] [Related]
3. Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients.
De A; Godse K; Dhoot D; Sarda A
Indian J Dermatol; 2021; 66(2):159-164. PubMed ID: 34188271
[TBL] [Abstract][Full Text] [Related]
4. Bilastine in Refractory Chronic Spontaneous Urticaria: Disease Control and Cytokine Modulation in an Open-label Prospective Study.
De A; Singh S; Chakraborty D; Sarda A; Godse K
Indian J Dermatol; 2024; 69(2):132-136. PubMed ID: 38841225
[TBL] [Abstract][Full Text] [Related]
5. A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria.
Shah B; Dhoot D; Choudhary A; Jangid N; Mistry D; Shah S; Kamat S; Barkate H
Clin Cosmet Investig Dermatol; 2022; 15():261-270. PubMed ID: 35221703
[TBL] [Abstract][Full Text] [Related]
6. Comparative Efficacy and Acceptability of Licensed Dose Second-Generation Antihistamines in Chronic Spontaneous Urticaria: A Network Meta-Analysis.
Phinyo P; Koompawichit P; Nochaiwong S; Tovanabutra N; Chiewchanvit S; Chuamanochan M
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):956-970.e57. PubMed ID: 32916325
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Up-dosed Second-generation Antihistamines in Uncontrolled Chronic Spontaneous Urticaria: A Review.
Podder I; Dhabal A; Chakraborty SS
J Clin Aesthet Dermatol; 2023 Mar; 16(3):44-50. PubMed ID: 36950042
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H
Chu CY; Al Hammadi A; Agmon-Levin N; Atakan N; Farag A; Arnaout RK; Kannenberg S; Kulthanan K; Mubarak A; Zaitoun F; Crowe S; Malfait S; Cooke K; Dekker EL
World Allergy Organ J; 2020 Apr; 13(4):100117. PubMed ID: 32382379
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
Hide M; Yagami A; Togawa M; Saito A; Furue M
Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of bilastine in reducing pruritus in patients with chronic spontaneous urticaria and other skin diseases: an exploratory study.
Serra E; Campo C; Novák Z; Majorek-Olechowska B; Pulka G; García-Bea A; Labeaga L
J Dermatolog Treat; 2020 May; 31(3):270-278. PubMed ID: 30835579
[No Abstract] [Full Text] [Related]
11. Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study.
Sinha VV; Kalikar MV; Mukhi JI; Giradkar AB; Sontakke S
Perspect Clin Res; 2023; 14(4):180-186. PubMed ID: 38025284
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
Ayse Ornek S; Orcen C; Church MK; Kocaturk E
Int Immunopharmacol; 2022 Nov; 112():109198. PubMed ID: 36115277
[TBL] [Abstract][Full Text] [Related]
13. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
Yagami A; Furue M; Togawa M; Saito A; Hide M
J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial.
Podder I; Das A; Ghosh S; Biswas D; Sengupta S; Chowdhury SN
Dermatol Ther; 2020 Nov; 33(6):e13946. PubMed ID: 32618048
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Up-dosing Antihistamines in Chronic Spontaneous Urticaria: A Systematic Review of the Literature.
Iriarte Sotés P; Armisén M; Usero-Bárcena T; Rodriguez Fernández A; Otero Rivas MM; Gonzalez MT; Meijide Calderón A; Veleiro B;
J Investig Allergol Clin Immunol; 2021 Jul; 31(4):282-291. PubMed ID: 33030434
[TBL] [Abstract][Full Text] [Related]
16. Up-dosing with bilastine results in improved effectiveness in cold contact urticaria.
Krause K; Spohr A; Zuberbier T; Church MK; Maurer M
Allergy; 2013 Jul; 68(7):921-8. PubMed ID: 23742030
[TBL] [Abstract][Full Text] [Related]
17. Cardiac safety of second-generation H
Cataldi M; Maurer M; Taglialatela M; Church MK
Clin Exp Allergy; 2019 Dec; 49(12):1615-1623. PubMed ID: 31519068
[TBL] [Abstract][Full Text] [Related]
18. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment.
Türk M; Yılmaz İ; Nazik Bahçecioğlu S; Can P; Ertaş R; Kartal D; Çınar SL; Kocatürk E
Dermatol Ther; 2021 Jan; 34(1):e14543. PubMed ID: 33190334
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Refractoriness to an Up to Fourfold Dosage of Antihistamines in Isolated Chronic Spontaneous Urticaria.
Wongjirattikarn R; Chaowattanapanit S; Foocharoen C; Sawanyawisuth K; Choonhakarn C; Julanon N; Utchariyaprasit E
J Cutan Med Surg; 2022; 26(6):593-599. PubMed ID: 36172833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
